| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | AGIOS PHARMACEUTICALS INC | 1,930,369 | 214,541,000 | 87.15% | ||
| 2 | SERES THERAPEUTICS INC | 599,297 | 24,871,000 | 10.10% | ||
| 3 | ELEVEN BIOTHERAPEUTICS INC | 1,907,008 | 5,378,000 | 2.18% | ||
| 4 | BG Medicine, Inc. | 1,764,286 | 970,000 | 0.39% | ||
| 5 | RENEWABLE ENERGY | 34,952 | 404,000 | 0.16% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-15-007759, filed 2015.07.28).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
